Epigenetics and Innate Immunity: the 'unTolld' Story

Overview

Journal Immunol Cell Biol

Publisher Wiley

Specialties Allergy & Immunology
Cell Biology

Date 2016 Mar 1

PMID 26924642

Citations 9

Authors

Conor Hennessy

Declan P McKernan

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors (TLRs) are a family of 13 receptors known as pattern-recognition receptors (PRRs) and have a key role in the innate immune response. The TLRs are activated by pathogen-associated molecular patterns (PAMPs) that are structurally conserved molecules present on the surfaces of bacteria and viruses. The activation of these TLRs by pathogens results in the downstream activation of genes involved in the production of proinflammatory factors. There is a lack of understanding on the mechanisms by which TLR gene expression is regulated. Epigenetics could be one such mechanism, which is concerned with changes in gene expression/products that arise without a change in the nucleotide sequence. These changes are brought about by two main mechanisms, DNA methylation and histone modifications. This review seeks to examine the current knowledge regarding the epigenetic regulation of this family of receptors and their signalling pathways.

Citing Articles

Context-dependent functions of pattern recognition receptors in cancer.

Man S, Jenkins B Nat Rev Cancer. 2022; 22(7):397-413.

PMID: 35355007 DOI: 10.1038/s41568-022-00462-5.

Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1.

Avbelj M, Hafner-Bratkovic I, Lainscek D, Mancek-Keber M, Peternelj T, Panter G Front Immunol. 2022; 12:790258.

PMID: 35069570 PMC: 8767097. DOI: 10.3389/fimmu.2021.790258.

Anti-Viral Pattern Recognition Receptors as Therapeutic Targets.

Hennessy C, McKernan D Cells. 2021; 10(9).

PMID: 34571909 PMC: 8466445. DOI: 10.3390/cells10092258.

Epigenetically regulated digital signaling defines epithelial innate immunity at the tissue level.

Clark H, McKenney C, Livingston N, Gershman A, Sajjan S, Chan I Nat Commun. 2021; 12(1):1836.

PMID: 33758175 PMC: 7988009. DOI: 10.1038/s41467-021-22070-x.

Innate immunity to malaria-The role of monocytes.

Dobbs K, Crabtree J, Dent A Immunol Rev. 2019; 293(1):8-24.

PMID: 31840836 PMC: 6986449. DOI: 10.1111/imr.12830.

References

Falkenberg K, Johnstone R . Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014; 13(9):673-91. DOI: 10.1038/nrd4360. View

Assmann T, Brondani L, Bauer A, Canani L, Crispim D . Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus. Eur J Endocrinol. 2014; 170(4):519-27. DOI: 10.1530/EJE-13-0963. View

Takahashi K, Sugi Y, Hosono A, Kaminogawa S . Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J Immunol. 2009; 183(10):6522-9. DOI: 10.4049/jimmunol.0901271. View

Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S . MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell. 1998; 2(2):253-8. DOI: 10.1016/s1097-2765(00)80136-7. View

Gursel I, Gursel M, Yamada H, Ishii K, Takeshita F, Klinman D . Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol. 2003; 171(3):1393-400. DOI: 10.4049/jimmunol.171.3.1393. View

Khor B, Gardet A, Xavier R . Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011; 474(7351):307-17. PMC: 3204665. DOI: 10.1038/nature10209. View

Poltorak A, He X, Smirnova I, Liu M, Van Huffel C, Du X . Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282(5396):2085-8. DOI: 10.1126/science.282.5396.2085. View

Jurkowska R, Jurkowski T, Jeltsch A . Structure and function of mammalian DNA methyltransferases. Chembiochem. 2011; 12(2):206-22. DOI: 10.1002/cbic.201000195. View

Bode K, Schroder K, Hume D, Ravasi T, Heeg K, Sweet M . Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology. 2007; 122(4):596-606. PMC: 2266046. DOI: 10.1111/j.1365-2567.2007.02678.x. View

10.

Colot V, Rossignol J . Eukaryotic DNA methylation as an evolutionary device. Bioessays. 1999; 21(5):402-11. DOI: 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.0.CO;2-B. View

11.

Maier H, Colbert J, Fitzsimmons D, Clark D, Hagman J . Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol Cell Biol. 2003; 23(6):1946-60. PMC: 149480. DOI: 10.1128/MCB.23.6.1946-1960.2003. View

12.

Goodman R, Smolik S . CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000; 14(13):1553-77. View

13.

Blander G, Guarente L . The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004; 73:417-35. DOI: 10.1146/annurev.biochem.73.011303.073651. View

14.

Shahbazian M, Grunstein M . Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem. 2007; 76:75-100. DOI: 10.1146/annurev.biochem.76.052705.162114. View

15.

Verdin E, Dequiedt F, Kasler H . Class II histone deacetylases: versatile regulators. Trends Genet. 2003; 19(5):286-93. DOI: 10.1016/S0168-9525(03)00073-8. View

16.

Bird A . Use of restriction enzymes to study eukaryotic DNA methylation: II. The symmetry of methylated sites supports semi-conservative copying of the methylation pattern. J Mol Biol. 1978; 118(1):49-60. DOI: 10.1016/0022-2836(78)90243-7. View

17.

Brogdon J, Xu Y, Szabo S, An S, Buxton F, Cohen D . Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood. 2006; 109(3):1123-30. DOI: 10.1182/blood-2006-04-019711. View

18.

Yang X, Seto E . HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene. 2007; 26(37):5310-8. DOI: 10.1038/sj.onc.1210599. View

19.

Riggs M, Whittaker R, Neumann J, Ingram V . n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature. 1977; 268(5619):462-4. DOI: 10.1038/268462a0. View

20.

Kiechl S, Lorenz E, Reindl M, Wiedermann C, Oberhollenzer F, Bonora E . Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002; 347(3):185-92. DOI: 10.1056/NEJMoa012673. View